Begell House作者，编辑及审稿者

Richard Gedrich

Kolltan Pharmaceuticals, Inc., New Haven, CT
Get more info about author from Directory of Specialists

Articles

Emerging Receptor Tyrosine Kinase Drug Targets: Implications for Antibody-Based Therapies for Oncology and Immunologic Disorders Vol. 20 '2015 - Critical Reviews™ in Oncogenesis